Analyst
Equibles does not estimate personal net worth.
Andrew Hamer has spoken on 2 investor events across 1 company, most recently for Cardiol Therapeutics Inc. on September 14, 2026. The companies whose calls Andrew Hamer spoke on are classified in the Healthcare sector.
“Well, we can be confident in the placebo event rate because it's very well established that the placebo event rate in this trial will be 75% recurrences and over a two- to three-month period.”
“So the most important information from the phase two trial was the reduction in events per year that occurred in the patients from on average 5.8 events per year of pericarditis recurrence to 0.9 events per year during the trial involvement.”
Drug Manufacturers - Specialty & Generic · Healthcare
